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Abstract. Agrin is an extracellular matrix (ECM) pro- 
tein with a calculated relative molecular mass of more 
than 200 kD that induces the aggregation of acetylcho- 
line receptors (AChRs) at the neuromuscular junction. 
This activity has been mapped to its COOH terminus. 
In an attempt to identify the functions of the NH2-ter- 
minal end, we have now characterized full-length chick 
agrin. We show that chick agrin encoded by a previ- 
ously described cDNA is not secreted from transfected 
cells. Secretion is achieved with a construct that in- 
cludes an additional 350 bp derived from the 5' end of 
chick agrin mRNA. Recombinant agrin is a heparan 
sulfate proteoglycan (HSPG) of more than 400 kD with 
glycosaminoglycan side chains attached only to the 
NH2-terminal half. Endogenous agrin in tissue homoge- 
nates also has an apparent molecular mass of >400 kD. 
While the amino acid sequence encoded by the 350-bp 
extension has no homology to published rat agrin, it in- 
cludes a stretch of 15 amino acids that is 80% identical 
to a previously identified bovine HSPG. The extension 
is required for binding of agrin to ECM. AChR aggre- 
gates induced by recombinant agrin that includes the 
extension are considerably smaller than those induced 
by agrin fragments, suggesting that binding of agrin to 
ECM modulates the size of receptor clusters. In addi- 
tion, we found a site encoding seven amino acids at the 
NH2-terminal end of agrin that is alternatively spliced. 
While motor neurons express the splice variant with the 
seven amino acid long insert, muscle cells mainly syn- 
thesize isoforms that lack this insert. In conclusion, the 
cDNAs described here code for chick agrin that has all 
the characteristics previously allocated to endogenous 
agrin. 
p 
ROPER synaptic transmission requires a high degree 
of cell specialization at the site of contact between 
pre- and postsynaptic cells. The best studied chemi- 
cal synapse is the neuromuscular junction (NMJ),  1 where 
the nerve terminal of a motor neuron synapses on a mus- 
cle fiber. The ingrowing motor axon initiates in muscle fi- 
bers a local accumulation of several proteins of the cyto- 
sol, the cell membrane and the extracellular matrix (ECM; 
for a review see Hall and Sanes, 1993).  The formation of 
these  specializations  in  the  muscle  fiber is  triggered by 
molecules released from the nerve (Frank and Fischbach, 
1979; Dahm and Landmesser, 1991). The best-character- 
ized  molecule  known  to  be  involved in  this  process  is 
agrin.  When added  to cultured myotubes, agrin induces 
the  aggregation of AChRs  and other molecules concen- 
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trated at the NMJ (Nitkin et al., 1987; Wallace, 1989). This 
process is believed to be mediated by binding of agrin to 
specific signaling receptors on the muscle cell surface (for 
reviews see Fallon and Hall, 1994; Bowe and Fallon, 1995). 
Active agrin is synthesized by motor neurons and is trans- 
ported to the nerve terminal where it is released and be- 
comes incorporated into the nascent muscle cell basal lam- 
ina (reviewed by McMahan, 1990).  Nevertheless, agrin is 
also found in nonsynaptic basal laminae of muscle, in kid- 
ney and capillaries (Reist et al., 1987; Fallon and Gelfman, 
1989; Godfrey, 1991; Rupp et al., 1991; Ruegg et al., 1992), 
suggesting that it may also have other functions. 
The molecular mass  of agrin deduced from cDNAs in 
rat, chick, and the marine ray is more than 200 kD (Rupp 
et al., 1991; Tsim et al., 1992; Smith et al., 1992). However 
a COOH-terminal, 45-kD fragment of agrin is sufficient to 
induce AChR clustering on cultured myotubes with high 
efficacy (Gesemann et al.,  1995).  Within this active frag- 
ment, two sites (called A and B in chick and ray, y and z in 
rat) whose positions and amino  acid sequences are con- 
served among the three species are subject to alternative 
mRNA splicing. When expressed in eukaryotic cells, only 
recombinant agrin isoforms with inserts at both sites are 
active in inducing AChR clusters, while those lacking in- 
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Ferns et al.,  1992,  1993; Gesemann et al.,  1995).  In vivo, 
transcripts encoding agrin isoforms are differentially dis- 
tributed.  The most  active ones are  expressed by cholin- 
ergic neurons, such as motor neurons of the spinal cord 
and ciliary ganglia neurons, and the inactive ones are highly 
expressed by nonneuronal cells like myotubes and Schwann 
cells (Ruegg et al., 1992; McMahan et al., 1992; Hoch et al., 
1993; Thomas et al., 1993; Smith and O'Dowd, 1994; Ma et 
al.,  1994,  1995).  Thus,  expression of specific isoforms is 
most likely the basis of the observed difference between 
muscle cell-derived and motor neuron-derived agrin in in- 
ducing AChR  aggregates  (Reist et al.,  1992;  Cohen and 
Godfrey, 1992). 
As in other extracellular matrix proteins, agrin consists 
of several repeated regions. There are nine Kazal inhibi- 
tor-like domains that are also found in follistatin, six EGF- 
like domains, and three globular domains homologous to 
COOH-terminal  domains  of laminin  a-chains.  Homolo- 
gous domains in other ECM molecules have been impli- 
cated in particular functions, such as cell--cell recognition 
and growth factor binding, which has led to many propos- 
als for additional functions of agrin (e.g., Patthy and Ni- 
kolics, 1993). The NHz-terminal half of agrin also contains 
several potential sites for carbohydrate attachment. There 
are five potential N-glycosylation sites, two serine/threo- 
nine-rich  regions,  and  at  least  six  potential  glycosami- 
noglycan (GAG) chain attachment sites. 
As  a first step in searching for additional functions of 
agrin isoforms, we aimed to express full-length chick agrin 
and to characterize its biochemical properties in more de- 
tail. When we transfected COS-7 cells with the previously 
described agrin cDNA (Tsim et al., 1992) the recombinant 
protein was not targeted to the ER and hence, was not se- 
creted from the cells. Here we present a chick agrin cDNA, 
whose coding sequence at the 5' end is extended by ~350 
bp. Agrin with this extension is secreted from transfected 
cells. The new sequence includes a stretch of 15 amino ac- 
ids that is highly homologous to a peptide previously char- 
acterized in a heparan sulfate proteoglycan (HSPG) of bo- 
vine kidney (Hagen et al., 1993).  Only recombinant agrin 
that includes this extension binds to Matrigel TM, a solubi- 
lized  mixture  of ECM  components.  Recombinant  chick 
agrin, depending on the inserts at site A and B, is active in 
inducing AChR aggregates on cultured myotubes. How- 
ever, AChR clusters are considerably smaller than those 
induced by fragments of agrin. In addition, we have found 
a  new 21-bp-long site  at the 5'  end that is  alternatively 
spliced. At early stages of synaptogenesis, motor neurons 
synthesize agrin mRNA with the 21-bp-long insert and the 
majority of agrin transcripts expressed in muscle lack this 
insert. In conclusion, these 5' extended constructs code for 
chick agrin isoforms that appear to fulfill all criteria to be 
full-length. 
Materials and Methods 
Polymerase Chain Reaction 
Conditions for PCR were as described elsewhere (Gesemann et al., 1995). 
Numbering of oligonucleotides is according to the sequences published by 
Tsim et al. (I992).  Oligonucleotides of new 5' sequences are negatively 
numbered. All PCR products used to generate expression constructs were 
cloned into PCR II cloning vector (lnvitrogen, San Diego, CA) and se- 
quenced to ensure that no mutations were introduced by DNA amplifica- 
tion. 
mRNA Isolation, Reverse Transcription and PCR 
Poly A + RNA was isolated with the Micro-FastTrack mRNA Isolation 
Kit (Invitrogen) according to the manufacturer's advice. RACE experi- 
ments (Frohmann et al., 1988; Loh et al., 1989) were performed with the 5' 
RACE System (GIBCO BRL, Gaithersburg, MD) according to the manu- 
facturer's advice. The oligonucleotide used for the reverse transcription 
reaction was as366 (CGTTGCTGTAGGTGGAATA) and the oligonu- 
cleotide  as232  (ATCCCTCGGCAGGCATCTCG) served as primer in 
the subsequent PCR reaction. Reverse transcriptase-polymerase chain re- 
action was conducted as described in Ruegg et al. (1992) except that Su- 
perscript  TM  II reverse transcriptase (GIBCO BRL) was used. To construct 
cDNAs  encoding  complete  agrin  isoforms,  first  strand  synthesis was 
primed with as366 and subsequent PCR was conducted using EcoRl_s- 
289 (GCATAGAATrCGGCTGCGGGCGATGGG) as the sense primer 
and as232 as the antisense primer (see also below). 
Chicken Genomic Library Screening 
A chicken genomic library from adult chicken liver (Clontech, Palo Alto, 
CA) was screened according to the manufacturer's advice. Recombinant 
phage (~9 x  105) from the amplified EMBL-3 library were screened with 
32p-labeled DNA probe (nucleotides 134 to 547; for location see Fig. 3). 
Hybridization was at 42°C in 5× SSC, 0.1% SDS, 5x Denhardt's reagent, 
30% formamide, and 0.1 mg/ml salmon sperm DNA. Filters were washed 
at a maximal stringency of 0.2× SSC, 0.1% SDS at 65°C.  Two rounds of 
dilution were  applied for cloning. DNA of positive recombinant phage 
was prepared as follows: 450 ml of 50 mM Tris-HC1, pH 7.5, 10 mM NaCI, 
8  mM  MgSO4,  0.01%  gelatin  were  inoculated  with  a  single  positive 
plaque. 60 ~1 of maltose-induced NM-538 (Sambrook et al., 1989)  in 10 
mM MgSO  4 (OD600 =  2) were added and incubated for 15 min at 37°C. 
After adding 30 ml of growth medium, 10 mM MgSO4, cells were incu- 
bated at 37°C until lysis. 300 t~1 chloroform were added and incubation 
was continued for another 45 min. The lysate was centrifuged for 15 min 
at 15,000 g to pellet cell debris. The supernatant was incubated with ap- 
proximately  100  p.g  DNase  (Boehringer  Mannheim,  Mannheim,  Ger- 
many) and 100 ~g RNase (Boehringer Mannheim) for 1 h at 37°C. 7 ml of 
20% PEG (6,000) in 2.5 M NaCI were added and incubation was contin- 
ued for 1 h on ice. After centrifugation for 15 min at 13,000 g, the pellet 
was dissolved in 450  /~1  10 mM Tris-HCl,  pH 8.0,  0.5%  SDS,  10  mM 
EDTA, 10 mM NaCI and 20 ~g proteinase K  (Boehringer Mannheim). 
Digestion was performed for 30 min at 60°C. After phenol/chloroform ex- 
traction, DNA was precipitated with ethanol. Inserts were excised by SalI 
digestion,  analyzed  on  agarose gel,  and  subcloned into  Bluescript  KS 
(Stratagene, La Jolla, CA). 
Alternative mRNA Splicing 
To examine the relative  abundance of agrin mRNA, randomly primed 
cDNAs were  subjected to  PCR using either primers s86 (CCCACCG- 
CAACGAGCTGATG) and as232, which flank the novel splice site, or 
primers  s5377  (TTTGATGGTAGGACGTACATG)  and  as5511  (CT- 
TCTGTT/TGATGCTCAGC), which flank the B site. PCR reaction was 
performed in 50 ~l containing 10% of reverse transcription mixture and 3 
×  105 cpm of 32p-end labeled oligonucleotide as232 or s5377 (Sambrook et 
al., 1989). After 30 rounds of amplification (94°C, 1 min; 56°C, 2 min; 72°C, 
2 min; final extension step of 10 min), 30%  of the reaction mixture was 
fractionated by electrophoresis on a 8% polyacrylamide gel. The relative 
amount of each PCR product was determined by analysis on a Phosphor- 
Imager (Molecular Dynamics, Sunnyvale, CA). 
Expression Constructs 
To  distinguish expression constructs from recombinant protein,  cDNA 
constructs are named with the prefix p followed by the name of the pro- 
tein they encode. All partial chick agrin cDNA constructs, with the excep- 
tion of pcFull  ps, pcNFull  ps, pcNAgrin, and pcAgrin (see below), contain 
the ER signal sequence of hemagglutinin of the avian influenza virus de- 
scribed by Tsim et al. (1992). 
cDNA constructs encoding the NH2-terminal part of chick agrin wei'e 
made as follows: for future use a myc epitope (Evan et al., 1985)  was in- 
serted at the COOH terminus of chick agrin. This was achieved by PCR 
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as5945  myc XbaI as the antisense primer (GGCCCTCTAGAACTAAT- 
TCAAGTCCTCCTCGCTGATTAACTITFGTTCTITGGCTA/GG/A- 
CAGTGTAATA) and pC95AOB0  as template. The gel-purified PCR prod- 
uct  was  cleaved  with  endonucleases Sail  and  Xbal  and  inserted  into 
pcDNA I  (Invitrogen) to  obtain pMyc. To fuse these sequences to  the 
NH2-terminal part of cFull  hs, a BamHI restriction site was introduced at 5' 
end  of the  myc epitope:  PCR  was performed  with  pMyc as template, 
BamHI_myc as sense primer (CGACTGGATCCAAGAACAAAAGT- 
TAAT)  and  SP6  as  the  antisense  primer  (CATI'TAGGTGACAC- 
TATAG). After digestion of the resulting PCR product with restriction 
endonucleases BamHI  and  XbaI,  the  BamHl/XbaI  fragment from pc- 
Full  h~ was replaced by the PCR product, yielding pcNFull  hS. The analo- 
gous NH2-terminal construct (pcNFull~) containing the putative ER sig- 
nal  sequence  as  proposed  by  Tsim  et  al.  (1992)  was  constructed  by 
replacing the SalI/XhoI fragment of pcNFull  hs with that of pcFull  pS. 
Construction  of  complete  chick  agrin  cDNA  was  accomplished by 
three cloning steps: PCR products encoding the 5' extension were excised 
from the PCR II cloning vector with endonucleases EcoRI and XhoI and 
subcloned into a modified pcDNA I vector lacking the BamHI restriction 
site. This construct was then fused to the region encoding the NH2-termi- 
nal half of agrin by digestion with XhoI and BamHI and subsequent liga- 
tion  to  the  corresponding cDNA  fragment of pcNFull.  The constructs 
were named pcNAgrin0 (no 21-bp insert) and pcNAgrin7 (with 21-bp in- 
sert). In the last step, sequence for the COOH-terminal part of chick agrin 
was fused to pcNAgrin  0 and pcNAgrin7 using BamHI and XbaI restriction 
sites. To generate complete chick agrin cDNAs with different A  and B 
sites, the corresponding pcFull  h~ constructs were used as parent constructs. 
Unless specifically stated, cDNA constructs used throughout this study 
contain  inserts  at  the  novel  site  and  lack  inserts  at  sites  A  and  B 
(pcAgrin7AoB0)- 
Antibodies 
To raise polyclonal antisera against cFuUhSA4B19,  the procedures described 
by Gesemann et al. (1995) were used. 
Tissue Culture and Transfections 
COS-7 cells (Gluzman, 1981)  were cultured in DME (GIBCO BRL) sup- 
plemented with 10% newborn calf serum, 10 mM sodium pyruvate, 100 U/ 
ml penicillin, and 100 p.g/ml streptomycin (all from GIBCO BRL). COS-7 
cells were transiently transfected with the DEAE-dextran-based method 
described by Cullen (1987). Chick myotube cultures were prepared as de- 
scribed (Gesemann et al., 1995). 
Metabolic Labeling, Immunoprecipitation, 
and Deglycosylation 
Metabolic labeling of intracellular proteins and immunoprecipitation fol- 
lowed by deglycosylation with endo-13-N-acetylglucosaminidase  H (Boehr- 
inger  Mannheim) was  essentially done  as  described  by Wessels et  al. 
(1991) with some minor modifications: cell lysis and immunoprecipitation 
was performed at 0.5 M  NaCl in the presence of 1 mM PMSF, 1 ixg/ml 
pepstatin, 10 i~g/ml aprotinin, 1 ~g/ml antipain, 1 p.g/ml leupeptin, and 1.75 
ixg/ml  benzamidin.  For  immunoprecipitation,  antiserum  raised  against 
cFnllhSA4B19  was used. Samples were analyzed by SDS-PAGE on a 4-10% 
gradient gel followed by fluorography. 
Immunoprecipitation of agrin in the conditioned medium was done as 
follows: 12 h  after transfection, growth medium was replaced by 1 ml of 
labeling  medium  (25%  DME,  65%  MEM  without  methionine,  10% 
IgG-depleted FCS, 10 mM sodium pyruvate, 100 U/ml penicillin, 100 p~g/ 
ml streptomycin; all from GIBCO BRL), and 50 p.Ci/ml [35S]methionine. 
48-72 h after transfection, 0.5 ml of the conditioned medium was subjected 
to immunoprecipitation as described by Gesemann et al. (1995) using ei- 
ther antisera recognizing cFullhSA4BI 9 or C95A4Bl 1. 
Heparansulfate glycosaminoglycan side chains were removed directly 
after immunoprecipitation. The immunocomplex on protein A-Sepharose 
beads was washed once with heparitinase incubation buffer (10 mM Tris- 
HCI pH 7.5, 50 mM sodium acetate, pH 7.5). 100 ill buffer and 0.05 U  of 
Heparitinase (Sigma Chemical Co., St. Louis, MO) was added and incu- 
bated  for 3  h  at 37°C.  Samples, released by adding 100 i~1 SDS-PAGE 
sample buffer and boiling, were then analyzed by SDS-PAGE on 3-12% 
gradient gel followed by fluorography. 
Immunoblot Analysis of Chick Tissues 
Tissues from Ell-E15 White Leghorn chick embryos were harvested and 
homogenized on ice with a 15 ml Dounce-homogenizer in the appropriate 
volume of PBS containing 1 mM PMSF, 1 ~g/ml pepstatin, 1 i~g/ml anti- 
pain, 10 p.g/ml aprotinin, 1 p.g/ml leupeptin, and 1.75  ~,g/ml benzamidin. 
Homogenized tissues were subjected to SDS-PAGE on a 3-12% gradient 
gel. Proteins (~100 p~g per lane) were transferred to nitrocellulose mem- 
branes (MiUipore, Marlborough, MA) according to Towbin et al. (1979) in 
the absence of methanol. The quality of protein transfer was tested by 
staining the membrane with Ponceau S  (Serva, Heidelberg,  Germany). 
Agrin-like immunoreactivity was visualized by the ECL method (Amer- 
sham, Buckinghamshire, UK). 
Enrichment of Motor Neurons 
Spinal cord segments were dissected from E5 White Leghorn chick em- 
bryos (developmental stages 26 and 27 according to the criteria of Ham- 
burger and Hamilton, 1951).  After digestion with 0.1%  trypsin in PBS 
containing 1% glucose for 30 rain at 37°C, the tissue was washed with 5 ml 
PBS supplemented with 300 U/ml DNase. A single cell suspension  was ob- 
tained by gentle trituration.  Cell debris were removed by centrifugation 
through a 3 ml cushion of 3.5% BSA in L-15, pH 7.4 for 15 min at 100 g. 
The cell pellet was resuspended in PBS, 0.5 mM EDTA. Motor neurons 
were  enriched by density centrifugation on metrizamide (Dohrmann et 
al., 1986),  by panning with mAb SC1  (Tanaka and Obata,  1984;  Bloch- 
Gallego et al., 1991),  or by metrizamide centrifugation followed by SC1 
panning. The  panning of spinal  cord  cells  on  SCl-coated  petri  dishes 
(Bloch-Gallego et al.,  1991)  was slightly modified in the following way: 
100  mm polystyrene Petri  dishes (Greiner,  Ntirtingen,  Germany) were 
coated with 10 ixg/ml purified IgG of mAb SC1 in 50 mM sodium carbon- 
ate buffer, pH 9.6. Dishes were washed twice with PBS and incubated with 
3% BSA in PBS for 1 h at room temperature. Cells were resuspended in 
MEM, 10% horse serum and incubated for 1 h at room temperature. The 
plates were washed four times with PBS with gentle swirling to remove 
nonadherent cells. Panned cells were lysed directly using the lysis buffer 
supplied by the Micro-FastTrack mRNA Isolation Kit. 
Immunocytochemistry 
Transiently transfected COS-7 cells were chilled to 4°C and anti-c95 anti- 
bodies (1:1,000)  were incubated for 30 min at 4°C. After three washes with 
DME, cells were fixed for 30 rain at 4°C and 30 min at room temperature 
with 4% paraformaldehyde, 11%  sucrose in 0.1 M  potassium phosphate 
buffer, pH 7.2.  After rinsing with PBS and 20 mM glycine in PBS, cells 
were permeabilized with 0.1%  saponin in PBS (PBSS).  10 p.g/ml IgG of 
mAb 5B1 in PBSS +  10% normal goat serum (NGS) was incubated for 2 h. 
After  four  washes  with  PBSS,  cells  were  incubated  for  1  h  with 
rhodamine-conjugated sheep anti-mouse IgG  (1/200;  Cappel,  Durham, 
NC) and fluorescein-conjugated goat anti-rabbit IgG (1/200;  Jackson Im- 
munoResearch Laboratories,  Inc.,  West  Grove,  PA)  in  PBSS  +  10% 
NGS. Cultures were washed with PBSS, mounted on glass cover slips with 
Vectashield  TM  (Vector  Laboratories, Inc., Burlingame, CA), and exam- 
ined with fluorescence microscopy. 
Quantification of  A ChR Aggregation 
Incubation of cultured chick muscle cells with agrin, labeling of AChRs 
with rhodamine-conjugated a-bungarotoxin, and quantification of AChR 
clusters using an imaging system (Image-I/AT; Universal Imaging, West 
Chester, PA) was done as described by Gesemann et al. (1995). Due to 
the small size of AChR clusters induced by cAgrinTA4B  8 and cAgrin0AgB  8 
aggregates with the longer axis of ~2 p~m were included. Concentration of 
recombinant agrin in conditioned medium of transfected COS cells was 
determined with an ELISA as described (Gesemann et al., 1995). 
Results 
The Coding Sequence of  Agrin Is Extended 
at the 5' End 
To study properties of the entire chick agrin, the overlap- 
ping cDNAs isolated by Tsim et al. (1992) were fused. This 
cDNA  construct  is  expected  to  encode  full-length agrin, 
Denzer et al. Full-length Chick Agrin  1549 Figure  1.  Structure  of chick 
agrin  and  of the  constructs 
used in this study. Conserved 
sites  for  glycosaminoglycan 
side  chain  attachment  and 
potential N-glycosylation are 
shown. Positions,  designation 
and  protein  sequence  of al- 
ternatively spliced inserts are 
given.  On  the  right  of each 
construct, the  name and  the 
isoforms  used  in  this  study 
are indicated. For future use, 
a myc-tag (Evan et al., 1985) 
was engineered to the COOH 
terminus of some constructs. 
which we called cFull  ps (for chick full-length with  putative 
signal  sequence;  Fig.  1).  COS-7  cells  were  transiently 
transfected  with  this  cDNA construct to obtain recombi- 
nant  protein.  The  presence  of cFull  ps in  the  conditioned 
medium was tested by immunoprecipitation  after labeling 
with [35S]methionine. No immunoreactive protein was de- 
tected in  the  supernatant  with  either mAb 5B1  (Reist  et 
al., 1987; data not shown) or a polyclonal antiserum raised 
against  the  95  kD,  COOH-terminal  fragment  of  chick 
agrin (Gesemann et al., 1995; Fig. 2), indicating that cFull  ps 
is not secreted from COS-7 cells. No agrin-like immunore- 
activity, as  assayed by immunohistochemistry,  was found 
associated  with  the  cell  surface  of transfected  COS  cells 
(data not shown). 
Soluble secretory molecules usually contain a  signal se- 
quence located at their NH2 terminus  that targets protein 
synthesis  to the  endoplasmatic  reticulum  (for review  see 
Verner and Schatz,  1988).  Such sequences  are character- 
ized by a stretch of 16-26 residues with a polar, basic NH2 
terminus  and a central hydrophobic core of 7-15 residues 
(von  Heijne,  1983;  Perlman  and  Halvarson,  1983).  Be- 
cause the NH2-terminal sequence of the cDNA of Tsim et 
al. (1992) does not meet these criteria, we replaced it with 
the signal sequence of hemagglutinin. The latter sequence 
is capable of targeting protein synthesis of agrin fragments 
to the secretory pathway (Tsim et  al.,  1992; Ruegg et  al., 
1992; Gesemann et  al.,  1995).  As shown in Fig. 2, cFull  hs 
(for chick full-length with hemagglutinin signal sequence; 
Fig. 1) accumulates in the medium of transfected cells. As 
reported previously (Gesemann et al., 1995), it has an ap- 
Figure 2.  Recombinant agrin 
is secreted from COS cells af- 
ter replacement of the puta- 
tive  signal  sequence  by  the 
signal sequence of hemagglu- 
tinin. COS-7 cells were trans- 
fected with cDNA described 
by Tsim et al. (1992), encod- 
ing full-length agrin (cFull  ps) 
or  with  cDNA  construct 
where the first  38 amino ac- 
ids at the NH2-terminus had 
been  replaced  by the  signal 
sequence  of  hemagglutinin 
(cFullhS). A mock transfection 
(Mock)  provided  a  control. 
Conditioned  medium  from 
[35S]methionine labeled COS 
cells was immunoprecipitated 
with anti-agrin antiserum, an- 
alyzed on 3-12% SDS-PAGE, 
and proteins were visualized 
by  fluorography.  No  agrin- 
like protein is detected with 
cFull ps  while  cFull  hs  is  effi- 
ciently secreted into the me- 
dium. As reported previously 
(Gesemann  et  al.,  1995), its 
apparent  molecular mass is  more  than  400  kD,  indicating  the 
high content of carbohydrates. Molecular weights in kD of stan- 
dard proteins are indicated. 
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chick  agrin  mRNA.  The 
cDNA sequence shown is the 
result of RACE experiments 
and  analysis  of  the  chick 
agrin gene. The sequence not 
described  in  Tsim  et  al., 
(1992) starts upstream of nu- 
cleotide  368  (*).  An  addi- 
tional  thymidine  that  neu- 
tralizes  the  in-frame  stop 
codon  is  located  at  nucle- 
otide  position  419  (I'). The 
shaded  area  depicts  the  ex- 
tended  NH2-terminal  se- 
quence. The new start codon 
at  nucleotide  position  91  is 
part of a consensus sequence 
for  initiation  of  translation 
(Kozak,  1986)  and  is  fol- 
lowed by 23 mainly hydrophobic residues  and the proposed signal sequence cleavage site at Asn 25 (circle;  von Heijne, 1986). Position 
and names of primers used for RACE experiments and RT-PCR are shown. The formerly proposed initiator  methionine at amino acid 
position 119 (bold), intron-exon boundaries ($) and a new potential N-glycosylation site at Asn 130 (0) are indicated. Note that the ho- 
mology between chick and rat agrin begins only at Lys 158 (L_.~). These sequence data are available from GenBank/EMBL/DDBJ under 
accession number U35613. 
parent  molecular  mass  of  400-600  kD  on  SDS-PAGE. 
This  result  shows  that  the  NH2-terminal  sequence  of 
cFull  ps does not serve as a signal sequence in COS cells. 
In an attempt to isolate the endogenous signal sequence 
of chick agrin, we performed RACE  experiments (£apid 
amplification of cDNA ends; Frohmann et al., 1988;  Loh 
et al., 1989) on poly A ÷ RNA from E5 to E6 chick spinal 
cord. Agrin-derived primers as366 used for reverse tran- 
scription,  and  as232  for  the  subsequent  anchored  PCR 
were both designed  to  anneal  at the  5'  end  of the  agrin 
mRNA where chick and rat agrin are still highly homolo- 
gous  (see Fig.  3).  We  analyzed more  thah  40  individual 
PCR  products.  The  longest  PCR  product  comprised  se- 
quences from position 107 through 620 (Fig. 3). In all the 
clones analyzed, an additional  thymidine residue was in- 
serted at position 419 (T, Fig. 3). This insertion neutralizes 
the in-frame stop codon upstream of the initiator methio- 
nine' postulated by Tsim et al. (1992) and extends the open 
reading  frame.  The  5'  end  of the  longest  PCR  product 
coded for a stretch of hydrophobic amino acids indicative 
of a signal sequence (von Heijne, 1983; Perlman and Hal- 
varson, 1983), but no new initiator methionine was found. 
Several  attempts  with  altered  conditions  did  not  yield 
longer RACE products (data not shown). One reason may 
be that the secondary structure of agrin mRNA induced a 
premature stop of reverse transcription (Sambrook et al., 
1989). 
We  therefore screened a  chick genomic library with a 
DNA probe spanning nucleotides 134 to 547 (for the loca- 
tion see Fig. 3). Out of 9 X 105 phages screened, two posi- 
tive  clones  were  analyzed.  In  both  clones,  an  in-frame 
ATG was found  16  nucleotides  upstream of the  longest 
PCR product. This ATG is part of a consensus for initia- 
tion of translation in eukaryotes (Kozak, 1986) and is fol- 
lowed  by 24  mainly hydrophobic  amino  acids  that  may 
serve as the signal sequence  (von Heijne, 1986).  In addi- 
tion, an in-frame stop codon is located 63 nucleotides up- 
stream of the potential site of initiation. To prove that these 
novel sequences are within the transcribed portion of the 
agrin  gene,  we  performed  a  reverse  transcriptase-poly- 
merase chain reaction (RT-PCR). Amplification was con- 
ducted using primers s-368 and as-273 (see Fig. 3). Although 
the yield was very low, the resulting PCR product had the 
expected size and could be re-amplified using the primer 
s-368 and a nested primer (data not shown). 
Recombinant Agrin with the Extension Is Secreted 
To generate a cDNA construct that covers the entire cod- 
ing sequence of chick agrin, RT-PCR was performed with 
the sense oligonucleotide EcoRI_s-289, spanning the puta- 
tive initiator  methionine,  and  the  antisense  oligonucleo- 
tide as232 (see Fig. 3). The PCR product was then fused 
to the cDNA encoding cFull  ps. The recombinant protein 
encoded by this  construct was called cAgrin (Fig.  1).  To 
show that cAgrin was targeted to the secretory pathway of 
COS cells, we investigated the endo-13-N-acetylglucosamini- 
dase  (endo  H)  sensitivity of freshly synthesized  protein. 
Endo H  removes N-linked carbohydrates that become at- 
tached to the protein backbone in the ER. A  decrease of 
the apparent molecular mass upon endo H  treatment indi- 
cates that the  protein is targeted  to the  ER.  To see this 
shift more clearly, we transfected COS cells with cDNA 
constructs  encoding  only the  NH2-terminal half (termed 
cNAgrin; see Fig. 1), which contains all the potential sites 
for N-linked glycosylation. After  a  pulse  of [35S]methio- 
nine for 30 min, the cells were lysed and agrin-like proteins 
were immunoprecipitated. After incubation with endo H, 
agrin was analyzed on SDS-PAGE. As shown in Fig. 4, the 
construct  with  the  signal  sequence  of  hemagglutinin, 
cNFull  hs,  is sensitive to  endo  H, indicating  that  the  pro- 
teins had reached the lumen of the ER where they became 
N-glycosylated.  In  contrast,  cNFull  ps  is  only weakly  ex- 
pressed and it is not sensitive to endo H  (Fig. 4). The rela- 
tive molecular mass of cNAgrin is also shifted by endo H 
digestion  (Fig. 4).  These results show that the new NH2- 
Denzer et al. Full-length Chick  Agrin  1551 Figure 4. Chick agrin containing the novel NH2-terminal  sequence 
is targeted to the endoplasmatic reticulum. COS-7 cells that were 
transiently transfected with cDNA constructs encoding NH2-ter- 
minal agrin fragments (see Fig. 1) were pulsed with [35S]methio- 
nine for 30 min.  Recombinant agrin was then isolated from the 
COS cell lysates by immunoprecipitation with anti-agrin antise- 
rum. Immunoprecipitates were incubated in buffer alone (-) or 
in  the  presence  of endo H  (+)  to determine  the  presence  of 
N-linked  carbohydrates.  Proteins  were  analyzed  on  a  4-10% 
SDS-PAGE. The apparent molecular mass of both cNFull  hs and 
cNAgrin is decreased upon Endo H treatment, indicating that the 
proteins had reached the lumen of the ER. In contrast, cNFull  p~ is 
only weakly expressed and is not sensitive  to endo H. The higher 
molecular  mass  of cNAgrin  compared  to  both,  cNFull  hs  and 
cN-Full  p~ is  consistent  with  its  123-amino  acid-long extension. 
Molecular weights in kD of standard proteins are shown. 
terminal  extension  of cAgrin targets  biosynthesis  to  the 
ER.  In addition,  they demonstrate  that agrin encoded by 
the previously proposed full-length  chick agrin cDNA is 
not targeted  to the ER confirming that  its  NHE-terminal 
sequence does not serve as signal sequence. 
Glycosaminoglycan Side Chain Attachment 
Several lines of evidence indicate that agrin is a HSPG: (a) 
Recombinant cFull  hs with  a  calculated  molecular mass of 
206 kD, when synthesized by COS-7 and 293 cells, has an 
apparent molecular mass between 400 and 600 kD (Gese- 
mann et al., 1995; Fig. 2 and 7). (b) Cloning of a previously 
characterized  major  HSPG  from  chick  brain  (Halfter, 
1993) has revealed that this HSPG is chick agrin (Tsen et 
al., 1995a). (c) Tryptic peptides derived from a HSPG iso- 
lated from bovine renal tubular basement membranes are 
highly homologous to chick agrin (Hagen et al., 1993; see 
below). 
When we tested the sensitivity of cFull  hs to chondroiti- 
nase  ABC and  keratanase,  its  molecular weight  was not 
decreased (data not shown), while heparitinase  treatment 
decreased  the  apparent  molecular  mass  (Fig.  5).  Agrin 
contains at least six potential GAG chain attachment sites 
with  the  consensus  sequence  E/DGSGE/D  or  SGXG 
(Bourdon et al., 1987; Zimmermann and Ruoslahti,  1989). 
Three sites are located in the 95-kD, COOH-terminal part 
of agrin  and  three  sites,  whose  positions  are  conserved 
across species,  are within the NH2-terminal  half (see Fig. 
Figure 5. Heparan sulfate glycosaminoglycan (HS-GAG) chains 
are attached to the NH2-terminal half of chick agrin. COS-7 cells 
were transfected with cDNA constructs encoding the proteins in- 
dicated (see Fig. 1). [35S]Methionine was included for 24 h and af- 
ter immunoprecipitation with anti-agrin antiserum, proteins were 
incubated in the  absence  (-)  or presence  (+)  of heparitinase. 
They were then separated on SDS-PAGE and visualized  by fluo- 
rography. Both, cFull  hs and cAgrin are sensitive  to heparitinase 
and  hence  carry  HS-GAG  chains.  The  NH2-terminal  half  of 
cFull h~ (lane cNFull  h~) is also sensitive  to heparitinase, while a 95 
kD, COOH-terminal fragment of agrin (c95) is insensitive,  dem- 
onstrating  that  only  the  NH2-terminal  part  of  agrin  carries 
HS-GAG  chains.  Molecular  weights  of standard  proteins  are 
given in kD. 
1).  To  see  which  of these  attachment  sites  in  fact  carry 
GAG side chains,  COS cells were  transiently  transfected 
with  cDNA constructs,  encoding cAgrin, cFull  hs, and the 
NH2-terminal  half (cNFull  hs) or the COOH-terminal  half 
(c95; see Fig. 1). As expected, incubation with heparitinase 
resulted  in the reduction of the apparent molecular mass 
of both  cFull  hs  and  cAgrin  (Fig.  5).  While  cNFull  hs,  the 
NHz-terminal  portion of cFull  hs, was deglycosylated with 
heparitinase,  the COOH-terminal fragment was not sensi- 
tive  to  the  enzyme (Fig.  5).  From  this  we conclude  that 
HS-GAG  chains  are  only attached  to  the  NHE-terminal 
portion of agrin. 
Agrin in Tissue Homogenates 
Independent  evidence  confirms  that  agrin  is  a  HSPG  in 
both  mammals  and  birds.  Hagen  et  al.  (1993)  isolated  a 
HSPG from basement  membranes  of bovine kidney and 
subsequently  determined  amino  acid  sequences  of three 
tryptic peptides. As shown in Fig. 6, two peptides are simi- 
lar to both chick and rat agrin. Peptides 2 and 3 are homol- 
ogous to sequences between  the first and the second fol- 
listatin  (PSTI)-like  domain  and  to  sequences  preceding 
the  first  follistatin  (PSTI)-like  domain  of agrin,  respec- 
tively. Peptide 1 maps however to the extension presented 
here.  These  data  provide  additional  evidence  that  the 
novel sequences  described  in this report  are indeed  con- 
tained  in  mature  agrin  and  that  they  are  conserved  be- 
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tween chick  and bovine agrin.  Alignment of three tryptic pep- 
tides  (single letter code) of a HSPG from bovine renal tubular 
basement membranes (BTBM; Hagen et al., 1993) with rat and 
chick agrin sequences.  Conserved amino acids are shaded.  Note 
that peptides 2 and 3 are homologous to both chick and rat agrin. 
Peptide 1 maps to a region  encoded by the novel 5' extension 
(box) and hence is homologous only to chick. The position of the 
initiator methionine of Tsim et al. (1992) is indicated  (A). 
tween  chick  and  bovine.  The  cDNA  encoding  rat  agrin 
(Rupp et al., 1991)  is not homologous to chick at its 5' end 
and consequently, it is not homologous to peptide 1 (Fig. 6). 
The calculated molecular mass of the protein backbone 
of chick agrin that includes  the  extension is 225  kD  and 
agrin synthesized by transfected cells has an apparent mo- 
lecular  mass of more  than  400  kD.  However,  agrin-like 
proteins  purified  from basal lamina extracts of different 
tissues and several species appear in two discrete doublets 
with  molecular mass of 150/135  and  95/70  kD  (Nitkin  et 
al.,  1987;  Godfrey et  al.,  1988a,b;  Godfrey, 1991).  Simi- 
larly,  Hagen  et  al.  (1993)  reported  a  calculated  relative 
molecular  mass  of  the  core  protein  after  heparitinase 
treatment of 145 and 125 kD. Hence, agrin seems to be de- 
graded during purification. To examine whether the high 
molecular weight form is found in vivo and to determine 
whether proteolytic fragments of the reported size are also 
detected  in  freshly  homogenized  tissue,  we  performed 
Western  blot  analyses.  To  prevent  proteolytic  degrada- 
tion, tissues were homogenized on ice in the presence of 
several protease inhibitors. Tissues examined were embry- 
onic day 14 (E14) brain (Fig. 7, lanes B), spinal cord (Fig. 
7, lanes S), hindlimb muscle (Fig. 7, lanes M), El0 vitreous 
humor (Fig.  7,  lanes  V), and  E15  liver (Fig. 7,  lanes L). 
Conditioned  medium  of 293  cells  that  had  been  stably 
transfected with cDNA encoding cFull  h~ provided a posi- 
tive control (Fig. 7, lanes C). Agrin-like proteins were de- 
tected  with  antisera  raised  either  against  the  95  kD, 
COOH-terminal part of agrin (Fig. 7 A), or against cFull  h~ 
(Fig.  7  B).  No  immunoreactivity was  observed with  the 
corresponding preimmune sera (data not shown) except in 
the  vitreous humor  where  the  preimmune  serum of the 
anti-c95 antiserum recognized two distinct bands of ~100 
and 125 kD (* in Fig. 7 A, lane V). Agrin-like immunore- 
activity was associated with a high molecular weight band 
in all tissues examined except liver (Fig. 7). The high mo- 
lecular weight agrin was most abundant in the vitreous hu- 
mor, followed by brain, muscle and spinal cord. It was seen 
more clearly with antibodies raised against cFull  h~ that car- 
ries HS-GAG chains (Fig. 7 B).  Since this band was also 
detected  with  antibodies  against c95  (Fig.  7 A), we con- 
clude that the antigen recognized by anti-cFull  hs antibod- 
Figure 7. Agrin in vivo is a high molecular weight protein of 400-- 
600 kD. Western blot analysis of different tissue homogenates us- 
ing either antiserum raised  against  the 95 kD, COOH-terminal 
half of agrin  (A) or cFull  hs (B).  Samples  correspond to: condi- 
tioned medium of 293 cells stably transfected with cDNA encod- 
ing cFull  hs (lane C), El4 brain (lane B), El4 and El5 spinal cord 
(lane S), El4 hindlimb  muscle (lane M), vitreous humor of El0 
eyes (lane  V), and E15 liver (lane  L). No immunoreactive pro- 
teins were detected with the preimmune sera, except in vitreous 
humor,  where  the  anti-c95  preimmune serum  recognized  two 
protein bands (* in A, lane V). Except in liver, agrin-like immu- 
noreactivity  in the high molecular weight range is detected in all 
the tissues examined,  suggesting that agrin in vivo is also a pro- 
teoglycan. Note that immunoreactive proteins of smaller size are 
present  in  most tissues  examined.  Arrows  in  lane  V indicate 
agrin-like proteins that have similar molecular mass as agrin frag- 
ments purified from Torpedo californica (see Nitkin et al., 1987). 
ies  is  agrin.  With  both  antisera,  several fragments were 
seen in most tissues. The detected fragments were some- 
times of different size, which may be due to the divergent 
specificities of the antisera. In liver, only the anti-c95 anti- 
bodies recognized a single band with a relative molecular 
mass of ~125 kD (Fig. 7 A, lane L). We have not charac- 
terized this  immunoreactive protein further.  However, a 
similar band has been observed in adult rat liver using an 
antiserum  raised  against  a  fusion  protein  encoding  se- 
quences just upstream of the 95-kD fragment (Rupp et al., 
1991).  The distribution into doublets of 150/135  and 95/70 
kD as observed by others (Nitkin et al., 1987;  Godfrey et 
al., 1988a,b; Godfrey, 1991) was not seen consistently in all 
the tissues. Immunoreactive protein bands of ~150 and 90 
kD  were  evident  only in  the  vitreous humor  (arrows in 
lanes V). At embryonic day 10, proteins secreted from ret- 
inal cells accumulate in this body fluid (e.g., Ruegg et al., 
1989; Halfter, 1993).  The presence of both high molecular 
weight band and agrin fragments therefore suggests that a 
fraction of agrin can be proteolyticaUy processed in vivo. 
Alternative Splicing of  Agrin mRNA at a Novel Site 
In our RACE experiments on mRNA isolated from E5 to 
E6 chick spinal cord, we obtained two populations of PCR 
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otide  and  deduced  amino acid sequence  of cDNAs  around  the 
novel splice site.  Numbering is according to Fig.  3.  (B) Autora- 
diogram of PCR products derived from randomly reverse tran- 
scribed mRNA of E5-E6 chick spinal cord (spinal cord) and of 
cultured chick myotubes (muscle).  PCR was performed using oli- 
gonucleotides flanking the novel splice site.  Control PCR using 
no template (1), cDNA with 21 bp (2), cDNA without 21 bp (3), 
or a mixture of both cDNAs (4).  Motor neurons of total spinal 
cord (T) were enriched  by panning spinal cord cells with mAb 
SC1 (S), by fractionating them on a metrizamide gradient (M), or 
by the  combination  of both  methods  (S÷M). The  last column 
(muscle) depicts PCR  products  from chick  myotubes grown in 
culture.  (C)  Quantification  of the  relative  abundance  of agrin 
mRNA including or lacking the 21-bp insert. For each lane 32p. 
counts were measured with a  Phosphorlmager and  the  relative 
abundance  of each  PCR  product  was  determined.  Values  are 
means -  SEM (n = 3). In E5/E6 spinal cord 82% of agrin mRNA 
includes the 21-bp insert (gray) and 18% lacks it. In muscle cells 
(lane muscle) the  ratio between  the  two transcripts  is reversed 
(19%  +  21 bp; 81%  -  21 bp). After enrichment for motor neu- 
rons by SC1  panning (lane S), metrizamide gradient centrifuga- 
tion (lane M) and a combination of both procedures (lane S+M) 
the amount of mRNA including  the 21 bp is increased  to 97%, 
suggesting that motor neurons express specifically this agrin tran- 
script. 
products  that  differed  by a  21-bp-long  insert  (Fig.  8  A). 
The peptide  EHRKLLA  encoded  by the insert is not ho- 
mologous to sequences in the database. Its position is close 
to the site where the homology between the chick and rat 
agrin cDNAs ends  (see also Fig. 3). Our analysis of the 5' 
end region of the chick agrin gene showed that this 21-bp 
insert  is preceded  by an intron  of at least 2  kb  (data  not 
shown; see Fig. 3 for intron-exon  boundaries).  Since both 
genomic clones  did  not  contain  sequences  further  down- 
stream of the  21-bp insert,  we  do  not  know whether  it is 
encoded  by a  separate exon.  Since such large introns  also 
have been  seen in  the  5'  region  of the  mouse  agrin gene 
(Rupp et al., 1992) this feature appears to be conserved. 
Alternative  mRNA  splicing at the previously character- 
ized  sites  A  and  B  differs  between  motor  neurons  and 
muscle cells (Tsim et al.,  1992;  Ruegg et al.,  1992;  McMa- 
han  et  al.,  1992;  Thomas  et  al.,  1993;  Hoch  et  al.,  1993; 
Smith and O'Dowd,  1994; Ma et al., 1995).  To investigate 
whether splicing at the novel site is also tissue dependent, 
we  performed  RT-PCR  on  mRNA  isolated  from  E12 
chick  hindlimb  muscle,  cultured  myotubes,  and  cell  frac- 
tions  from E5  (stages 26  and  27;  Hamburger  and  Hamil- 
ton,  1951)  chick  spinal  cord.  The  majority of mRNA  ex- 
pressed in spinal cord contains  the  21-bp insert  (Fig.  8, B 
and  C, spinal cord, lane  T), while conversely, muscle cells 
synthesize mainly mRNA  lacking this insert  (Fig.  8 B  and 
C, muscle). Since we were interested  in the distribution  of 
the  splice  variants  in  motor  neurons,  we  either  panned 
freshly  dissociated  spinal  cord  cells  on  petri  dishes  that 
had been coated with mAb SC1, which recognizes an anti- 
gen  expressed  by  motor  neurons  and  floor  plate  cells 
(Tanaka  and  Obata,  1984;  Bloch-Gallego  et al.,  1991),  or 
separated them from other cells according to their size on 
a  metrizamide  gradient  (Dohrmann  et  al.,  1986).  Finally, 
both  methods  were  applied  sequentially  to  eliminate 
small, SCl-positive cells  (Tanaka and  Obata,  1984).  With 
each enrichment  the relative content of agrin mRNA con- 
taining the 21-bp insert increased  (Fig.  8, B  and  C, spinal 
cord, compare lanes  T through S+M).  In the cell fraction 
with the highest content in large, SCl-positive motor neu- 
rons (lane S+M) 97%  of the  agrin mRNA  contained  the 
21 bp (Fig. 8 C). As an independent  control for the enrich- 
ment,  we  also  determined  the  relative  amount  of  agrin 
mRNA  containing  inserts at site B  (data not shown).  The 
relative  abundance  of individual  splice variants for site B 
was similar to that reported by Smith and O'Dowd (1994) 
for single ciliary ganglia neurons and obtained earlier with 
the same preparation (McMahan  et al., 1992; Honig, L. S., 
M. J. Werle, S. E. I-Iorton, and M. A. Ruegg, manuscript in 
preparation).  In  summary,  we  conclude  that  splicing  of 
agrin  mRNA  at  the  novel  site  is regulated.  While  motor 
neurons  express agrin mRNA  with  the 21-bp insert,  mus- 
cle cells synthesize mainly agrin mRNA lacking this insert. 
Binding of  Recombinant Agrin to Extracellular Matrix 
Requires the NH2-terminal Extension 
Agrin was originally purified from basal lamina extracts of 
the electric organ of Torpedo californica  (Nitkin et al., 1987). 
Moreover, agrin-like immunoreactivity remains associated 
with  synaptic  basal  lamina  for  at  least  three  weeks  after 
degeneration  of the  cells  at the  NMJ  (Reist  et al.,  1987). 
The Journal of Cell Biology, Volume 131, 1995  1554 Figure 9. Binding of recombinant agrin to extracellular matrix requires the NH2-terminal extension. Double immunofluorescence  stain- 
ing of transiently transfected COS-7 cells grown on Matrigel  TM. The constructs and agrin isoforms used are indicated on the left of each 
row (see Fig. 1 for structure of the constructs). Extracellular agrin (nonpermeabilized) was visualized by incubating  COS cells with anti- 
bodies directed against the 95 kD, COOH-terminal fragment at 4°C for 30 min and an appropriate, fluorescein-conjugated  secondary 
antibody. To identify transfected cells, cells were permeabilized and agrin was subsequently  visualized with mAb 5B1 and a rhodamine- 
conjugated secondary antibody (permeabilized). No deposition of agrin in Matrigel  TM is observed with C95AaB8  and cFullh~A4B8  (A and B), 
while agrin is deposited in a gradient with both constructs that include the extension, cAgrinoAaBs  and cAgrinTA4B  8 (C and D). Bar, 40 I~m. 
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also must bind to basal lamina (McMahan, 1990). To local- 
ize the region in agrin that confers its binding to ECM and 
to test whether alternative mRNA splicing affects the bind- 
ing,  transiently transfected COS  cells were grown over- 
night on MatrigeF  M, a solubilized basement membrane ex- 
tracted from the Engelbreth-Holm-Swarm (EHS) mouse 
sarcoma (Kleinman et al., 1982).  Deposition of agrin iso- 
forms was assayed by extracellular staining with antibod- 
ies directed against the 95-kD COOH-terminal fragment 
of agrin. COS cells were then permeabilized and stained 
with mAb 5B1  (Reist et al.,  1987)  to identify transfected 
cells. No deposits in Matrigel  TM are detected with cells that 
express the 95-kD COOH-terminal fragment of agrinA4B8 
(Fig. 9 A) although intracellular staining shows that C95A4B8 
is synthesized (Fig. 9 A'). The cDNA construct encoding 
recombinant agrin, eFullbSA4B8,  that does not include the 5' 
extension shows the same staining pattern as C95A4B8 (Fig. 
9, B and B'). In contrast, cAgrinTA4BS,  a splice variant that 
includes  the  7-amino  acid insert at the  new site,  is  effi- 
ciently deposited in the MatrigeF  M predominantly in the 
vicinity of transfected COS cells (Fig. 9 C). Exclusion of 
the 7-amino acid insert at the new site did not change the 
staining pattern on Matrigel  TM (Fig. 9 D, but see below). 
Similarly, no effect of splicing at sites A  and B  was  ob- 
served (data not shown). No staining was observed on the 
cell surface of COS cells. This contrasts results by Cam- 
panelli et al.  (1991) where full-length rat agrin remained 
associated with the cell surface. The close association of 
the  COS cells with MatrigeF  M also prevented anti-agrin 
antibodies from staining  extracellular agrin  at  the  basal 
site  of the  transfected cell.  After  permeabilization,  the 
staining with mAb 5B1 was much stronger when COS cells 
had been transfected with constructs including the exten- 
sion than with cDNAs lacking it (compare Fig. 9, A' and 
B'  with  C'  and  D'),  suggesting  that  agrin  was  also  de- 
posited on the basal site of the COS cells. The deposition 
of recombinant agrin was not seen on uncoated or gelatin- 
coated tissue culture dishes  (data not shown), indicating 
that  the  binding  occurs  to  specific  components  of  the 
Matrigel  TM. 
To quantify the binding of recombinant agrin to Matri- 
gel  TM and to see whether alternative splicing at the novel 
site may influence this binding, we next compared the con- 
centration of recombinant protein in the conditioned me- 
dium of transiently transfected COS cells that were either 
grown on normal tissue culture dishes or on Matrigel  TM- 
coated dishes. As shown in Table I, no significant differ- 
ence in the concentration of recombinant agrin on either 
substrate  was  seen with C95A4BS and cFullbSA4B8  . In con- 
trast,  the  concentration  of  recombinant  agrin  that  re- 
mained soluble on MatrigelXM-coated  dishes was less than 
50%  with both constructs that include the  5'  extension. 
Moreover, in two independent experiments, considerably 
more cAgrin0A4B8 was bound to Matrigel  TM than cAgrinTAaB  s. 
Hence, alternative splicing at the novel site may influence 
binding of agrin to extracellular matrix. 
The NHz-terminal Extension Influences Size But Not 
Extent of  Agrin-induced A ChR Clusters 
AChR-aggregating activity of agrin is strongly regulated 
Table I. Relative Concentration of Recombinant Agrin in the 
Medium of Transiently Transfected COS Cells Plated on 
MatrigelrM-coated Dishes 
Protein  Plastic  Matrigel 
mean  +- SEM  mean  -+ SEM 
C95A4/38  100.0 ----- 3.4  99.2 --+ 3.2 
cFulI~SA4B8  100.0 --+ 4.8  100.7 _+ 2.4 
cAgrin7A4B8  100.0 ±  1.7  45.2 --+ 1.2 
cAgrin0A4a8  100.0 ±  3.4  22.3 ___  1.8 
COS cells were transfected with cDNAs encoding the indicated agrin constructs. One 
day after transfection, cells were replated in the same density on regular tissue culture 
dishes (plastic) or on MatrigelTM-coated dishes (Matrigel). After l 8 h, conditioned me- 
dium was collected and the concentration of recombinant agrin was determined by 
ELISA as described in  Materials and Methods.  Concentration of agrin with cells 
grown on regular tissue culture dishes was set as 100%. Values are means -+ SEM of 
two independent experiments with triplicate cultures for each condition. The concen- 
tration of C95A4B8 and cFulIhSA~B8  and cFulIhSAaB8  does not change, indicating that these 
constructs do not bind to Matrigel  TM. In contrast, both cAgrin7AaB  8 and cAgrin0A4B8 
bind to Matrigel  TM. Note also the difference in binding to Matrigel  TM between agrin 
constructs with different inserts at the novel splice site. 
by the alternatively spliced inserts A  and B (Ruegg et al., 
1992; Ferns et al., 1992, 1993; Gesemann et al., 1995). The 
dependence of activity on these inserts was observed with 
95-kD COOH-terminal fragments and those that included 
the NH2-terminal part of agrin (cFullbs; Gesemann et al., 
1995).  To test whether recombinant agrin isoforms with 
the extension were also active in AChR aggregation in an 
isoform-specific manner we incubated cultured chick myo- 
tubes  for  16  h  with  an  excess  of recombinant  protein. 
AChRs were visualized using rhodamine-labeled a-bunga- 
rotoxin. No AChR clustering was detected after incuba- 
tion with conditioned medium of mock-transfected cells 
(Fig. 10 A). Agrin isoforms that lacked the A and the B in- 
serts also did not induce receptor clustering (cFullhSAoB0, 
Fig. 10 C; cAgrinTAOB0, Fig. 10 E; cAgrin0AOB0, Fig. 10 G). 
As shown previously, clustering of AChRs was clearly in- 
duced by 500 pM of C95A4BS (Fig.  10 B) and cFullhSA4B8 
(Fig.  10 D).  Agrin isoforms that included the  extension 
were also activ~ in inducing AChR clusters (cAgrin7AaBS, 
Fig. 10 F; cAgrin0AaBS, Fig. 10 H). AChR clusters induced 
by these constructs were however smaller and more fre- 
quent (Fig. 10, F and H) than those induced by agrin frag- 
ments (Fig 10, B and D). The average size of AChR clus- 
ters induced by cFullh~A4B  s in 20 myotube segments was 
26.2  _+  2.3  p,m  2  (mean  __+  SEM),  while  induction  by 
cAgrin7A4BS yielded clusters with an average size of 10.8 --- 
0.6 ixm  2 (mean __- SEM). To determine whether the change 
in size was based on decreased AChR-aggregating activity, 
we measured the area of AChR clusters with a computer- 
ized image analysis system. As shown in Fig.  10 I, there 
was  no  significant  difference between  active  agrin  iso- 
forms  that  have  the  extension  and  their  corresponding 
fragments. The distribution of AChR clusters (aligned ver- 
sus dispersed; compare Fig. 10, F and H) sometimes varied 
between cAgrinTAaB8 and cAgrin0AaB8. However, we could 
not reproduce this phenomenon consistently. In summary, 
these results show that AChR-aggregating activity of com- 
plete chick agrin depends on splice inserts at sites A and B 
and that the most NH2-terminal sequence of agrin alters 
the size of the induced clusters but not the overall extent 
of the induction. 
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AChR clusters. Fluorescence  micrographs of cultured chick myo- 
tubes labeled with  rhodamine-a-bungarotoxin. Myotubes were 
incubated for 16 h with conditioned  medium of COS cells, that 
had been mock-transfected (A) or with cDNAs encoding C95A4BS 
(B), cFullhSAoB0 (C), cFullhSA4B8 (D), cAgrin7n0B  0 (E), cAgrin7A4B  8 
(F), cAgrin0g0B0 (G) and cAgrin0a4Bs (H). The concentration of 
recombinant agrin was always 500 pM.  Only agrinn4B8 isoforms 
induced  AChR aggregates  (B, D, F,  and H), whereas agring0ao 
isoforms were inactive (C, E, and G). Active agrin including the 
extension  (cAgrin7ggBs, F; cAgrin0A4BS, H) induced  smaller clus- 
ters. Bar, 50 ~m. (/) Quantification  of AChR aggregation. Due to 
the smaller size of AChR clusters  induced  by active  agrin  iso- 
forms  that  include  the  extension  AChR  aggregates  with  the 
longer axis/>2 p.m are included. Activity is expressed as percent- 
age area of AChR clusters. Each data point represents mean _+ 
SEM  of duplicate  cultures,  where  10  myotube segments were 
counted in each. The control corresponds to myotubes incubated 
with conditioned  medium of mock-transfected COS cells. Results 
of one representative experiment are shown. 
Discussion 
Differences between Chick and Rat Agrin 
We report here the heterologous expression of chick agrin 
comprising  all  the  functional  properties  that  have  been 
postulated for endogenous  agrin  (McMahan,  1990).  This 
was achieved by ligating the novel 5' end sequences to the 
cDNAs described by Tsim et al.  (1992).  When grown on 
noncoated  tissue  culture  dishes,  two  different  cell  lines 
transfected  with  this  construct  secrete  the  recombinant 
protein into the medium (Figs. 5 and 7), This contrasts the 
results of Campanelli et al. (1991) where recombinant full- 
length rat agrin remained associated with the cell surface 
of transfected  COS  and  CHO  cells.  Comparison  of the 
protein sequences of chick and rat agrin suggests that the 
difference  resides  in  the  NH2 terminus.  Although  chick 
and rat agrin are highly conserved (60% identity), no ho- 
mology is found in the previously postulated putative sig- 
nal  peptides  (Rupp  et  al.,  1991;  Tsim et  al.,  1992).  The 
80% identity of the 15-amino acid peptide of bovine kid- 
ney HSPG with a corresponding stretch in the 5' extended 
region in chick (Fig. 6) shows that the formerly postulated 
signal sequence of chick agrin is in fact part of the mature 
protein, This, together with our finding that the extension 
is important for the binding of agrin to ECM, makes it very 
likely that rat agrin also contains a homologous stretch. The 
published NH2-terminal sequence of rat agrin (Rupp et al., 
1991)  is  however  completely different  to  our  extension 
and to the bovine peptide and may therefore be derived 
from a rat agrin mRNA that encodes an alternative 5' se- 
quence. 
The calculated relative molecular mass of chick agrin is 
225  kD. When expressed in COS and 293 cells, recombi- 
nant chick agrin has  a  relative molecular mass of 400  to 
600 kD  (Fig. 5)  due  to the  attachment of carbohydrates. 
Similarly, agrin-like immunoreactivity in  tissue homoge- 
nares has the same apparent molecular mass (Tsen et al., 
1995a; Fig. 7). Full-length rat agrin expressed by COS cells 
and agrin-like protein in rat tissue homogenates has how- 
ever an apparent molecular mass of ~200 kD (Rupp et al., 
1991;  Campanelli et al., 1991).  In addition, ray and chick 
agrin-like proteins in earlier studies appear as distinct pro- 
tein  bands  between  150  and  70  kD  (Nitkin  et  al.,  1987; 
Godfrey et al., 1988a,b; Godfrey, 1991).  The difference in 
the  molecular mass observed earlier and our results sug- 
gests that  the  previously described  immunoreactive pro- 
teins result from degradation. Although we observed sev- 
eral  smaller  protein  bands  in  our  Western  blots,  the 
presence of agrin-like protein at a high molecular mass in- 
dicates that agrin in vivo can be released from cells with- 
out  proteolytic processing.  One  possible  explanation  for 
the  absence of the  high molecular mass bands in  earlier 
studies may be that the antibodies used were directed ei- 
ther against the nonglycosylated, COOH-terminal part of 
agrin or against fusion proteins expressed in Escherichia 
coll. As shown in Fig. 7, such antibodies have a lower avid- 
ity for the highly glycosylated agrin. 
Possible Role of Agrin as a Heparan 
Sulfate Proteoglycan 
We show here that sites within the NH2-terminal half of 
agrin  carry  N-linked  carbohydrates  and  HS-GAG  side 
chains  (Figs. 4  and 5),  and that the  COOH-terminal end 
lacks these  glycosylations. The  attachment of GAG side 
chains is not necessary for agrin's activity to induce AChR 
clusters (Gesemann et al., 1995). Several lines of evidence 
suggest however that HSPGs expressed by the muscle cells 
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don et al.,  1993).  We have therefore recently postulated 
that agrin may bind to HSPGs expressed in muscle cells 
and that these HSPGs may help to present agrin to its pos- 
tulated  signal-transducing  receptor  (Gesemann  et  al., 
1995). Because agrin expressed by muscle cells is a HSPG 
(Fig.  7)  and  because  it  accumulates  at  AChR  clusters 
(Lieth et al., 1992), muscle agrin itself may be such a helper 
protein. Indeed, the 95-kD fragment of the active isoform 
agrinAaB8 binds weakly to the longer, inactive recombinant 
cFullhSAoB0 that carries HS-GAG chains  (Gesemann, M., 
A. J. Denzer, and M. A. Ruegg, unpublished observation). 
Agrin's  role  as  a  HSPG  may be  similar  to  those  de- 
scribed for other HSPGs. They are believed to play a role 
in the scaffold for the attachment of various ECM compo- 
nents and to modulate interactions with cells during mor- 
phogenesis (for a review see Timpl, 1993). The presence of 
HS-GAG chains together with a  similar  arrangement of 
structural  motifs  makes  agrin  a  homologue  to  perlecan 
(Noonan et al., 1991). Perlecan is a low affinity, auxiliary 
receptor  for  basic  fibroblast  growth  factor,  a  potent 
growth factor involved in  angiogenesis,  and  this  interac- 
tion is dependent on its HS-GAG chains (Aviezer et al., 
1995).  Since agrin is highly expressed during the develop- 
ment  of  the  nervous  system  (McMahan  et  al.,  1992; 
O'Connor et al.,  1994; Ma et al.,  1994),  it may have func- 
tions similar to those described for perlecan (reviewed in 
Iozzo et al.,  1994).  Recent evidence suggests  that  agrin, 
which is also expressed in axonal tracts of the developing 
chick  visual  system  (Halfter,  1993),  modulates  the  ho- 
mophilic binding of the cell adhesion molecule N-CAM. 
This function depends on the presence of HS-GAG chains 
in agrin and hence is constricted to its NH2-terminal half 
(Burg et al., 1995). 
Binding of  Agrin to Extracellular Matrix and 
A ChR-aggregating Activity 
We show that binding of agrin to ECM, detected as a dep- 
osition in Matrigel  TM, requires the novel NH2-terminal se- 
quence (Fig. 9). This preparation of solubilized basement 
membrane contains mainly laminin-1 (EHS laminin), col- 
lagen  IV,  HSPGs,  and  nidogen  (Kleinman et  al.,  1982). 
Hence, any of these proteins may be a binding partner for 
agrin. Deposition of agrin-like immunoreactivity on a sim- 
ilar substrate has also been observed with spinal cord neu- 
rons of Xenopus laevis (Cohen et al., 1994), supporting our 
conclusion that the construct we describe here codes for 
the entire chick agrin. 
AChR aggregates induced by this construct are smaller 
than those induced by agrin fragments. Small AChR ag- 
gregates  (<4  p~m  2)  are  formed  within  two  hours  when 
agrin  isolated from Torpedo californica is  added  to me- 
dium  bathing  chick  myotubes. Their size increases with 
time and reaches a  maximum after 16 to 20 h  (Wallace, 
1988). This increase in size is, at least in part, based on the 
fusion of the small aggregates (Wallace, 1994).  It is con- 
ceivable that Torpedo agrin bound to its postulated signal- 
transducing receptor is still mobile in the muscle cell mem- 
brane. Therefore, small clusters can merge to form bigger 
clusters. Because the partially purified agrin from Torpedo 
californica used in these studies contains mainly COOH- 
terminal fragments (Nitkin et al., 1987), it does not bind to 
ECM.  We propose that recombinant agrin including the 
extension, which additionally binds to ECM, immobilizes 
the small clusters and prevents them from merging, or, al- 
ternatively, prolongs the time needed for the fusion. 
Alternative mRNA Splicing  at the Novel Site 
Is Regulated 
We also describe a site of 21-bp length that undergoes al- 
ternative mRNA splicing. As reported for sites A  and B, 
the splice variants are expressed differentially by presyn- 
aptic motor neurons and postsynaptic muscle cells (Fig. 8). 
As embryonic day 5 to 6 motor neurons (HH stage 26 and 
27; Hamburger and Hamilton, 1951) extend their axons to 
muscle, AChRs  begin to cluster in response to these in- 
growing axons (Dahm and Landmesser, 1991). This is also 
the time when motor neurons express high levels of SC1 
(also  known  as  DM-GRASP  or  BEN;  Pourquie  et  al., 
1990; Burns et al.,  1991). In the purest preparation of mo- 
tor neurons, 97% of agrin mRNA contains the 21-bp in- 
sert. In this cell fraction more than 95 % are motor neurons 
(Bloch-Gallego  et  al.,  1991).  Hence,  the  3%  of  agrin 
mRNA  lacking  the  21-bp  insert  most  likely  represents 
contamination  by  nonmotor  neurons  and  we  conclude 
that, early in synaptogenesis, chick motor neurons synthe- 
size agrin mRNA  that contains the 21-bp insert. On the 
other hand, in postsynaptic cells, such as El2 (HH stage 
38; Hamburger and Hamilton, 1951) hindlimb muscle and 
myotubes grown in culture, the majority of agrin mRNA 
lacks the 21-bp insert. El0 dorsal root ganglia also synthe- 
size predominantly agrin mRNA containing the 21-bp in- 
sert and Schwann cells of the sciatic nerve have a pattern 
similar to muscle cells (Denzer, A. J., and M.  A. Ruegg, 
unpublished data). This suggests that neurons other than 
motor neurons synthesize agrin mRNA containing the 21 
bp  while  nonneuronal  cells  show  a  preference  for  the 
splice variant lacking this insert. Indeed, Tsen et al. (1995b) 
have obtained similar results in  the central nervous sys- 
tem,  suggesting  that  nonneuronal  cells  express  mainly 
agrin isoforms lacking the 21-bp insert and neurons syn- 
thesize agrin  mRNA  that contains the 21-bp  insert.  We 
have not closely looked at functional differences between 
the splice variants. Our finding that the isoforms seem to 
bind to MatrigeV  M with different strength (Table I) sug- 
gests that this insert may regulate the interaction of agrin 
with  ECM.  We  are  currently  aiming  at  identifying the 
binding partners of agrin in the ECM and studying in de- 
tail whether splicing at the novel site affects binding. 
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